High FoxP3+ Tregs infiltration was significantly associated with shorter survival in the most solid tumors, including cervical, renal, melanomas, and breast cancers, whereas FoxP3+ Tregs were associated with improved survival in colorectal, head and neck, and esophageal cancers. This evidence concerns the gene FOXP3 and breast carcinoma.